Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations

Autor: Dzhioeva O, Belyavskiy E

Publikováno v: Therapeutics and Clinical Risk Management, Vol Volume 16, Pp 769-785 (2020)

Olga Dzhioeva,1 Evgeny Belyavskiy2 1Department of Fundamental and Applied Aspects of Obesity, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia; 2Department of Internal Medici

Externí odkaz: https://doaj.org/article/813b136547dc4162b68733efb1ca0fbb

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial:Journal of Hypertension

Autor: Tomaschitz, A., Verheyen, N., Meinitzer, A., Pieske, B., Belyavskiy, E., Brussee, H., Haas, J., Marz, W., Pieske-Kraigher, E., Verheyen, S., Ofner-Ziegenfuss, L., Hartaigh, Briain O., Schwetz, V., Aberer, F., Grubler, M., Lang, F., Alesutan, I., Voelkl, J., Gaksch, M., Horina, J.H., Dimai, H. P., Rus-Machan, J., Stiegler, C., Ritz, E., Fahrleitner-Pammer, A., Pilz, S.

Publikováno v: Tomaschitz, A, Verheyen, N, Meinitzer, A, Pieske, B, Belyavskiy, E, Brussee, H, Haas, J, Marz, W, Pieske-Kraigher, E, Verheyen, S, Ofner-Ziegenfuss, L, Hartaigh, B O, Schwetz, V, Aberer, F, Grubler, M, Lang, F, Alesutan, I, Voelkl, J, Gaksch, M, Horina, J H, Dimai, H P, Rus-Machan, J, Stiegler, C, Ritz, E, Fahrleitner-Pammer, A & Pilz, S 2016, ' Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial : Journal of Hypertension ', Journal of Hypertension, vol. 34, pp. 1347-1356 . https://doi.org/10.1097/hjh.0000000000000927
Journal of Hypertension, 34, 1347-1356. Lippincott Williams and Wilkins

Background: Accumulating evidence points toward mutual interaction between parathyroid hormone (PTH) and aldosterone as potential mechanism for increasing cardiovascular risk in primary hyperparathyroidism (pHPT). Methods: The Eplerenone on parathyro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7ed9a9d22d698e53c808fca206597817
https://research.vumc.nl/en/publications/defccd6f-e9f5-4499-9e35-16269e20843b

Plasma Parathyroid Hormone Is Independently Related to Nocturnal 3. Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study

Autor: Verheyen, N.D., Kienreich, K., Gaksch, M., van Ballegooijen, A.J., Grübler, M.R., Hartaigh, B.O., Schmid, A., Fahrleitner-Pammer, A., Kraigher-Krainer, E., Colantonio, C., Belyavskiy, E., Treiber, G., Catena, C., Brussee, H., Pieske, B., März, W., Tomaschitz, A., Pilz, S.

Publikováno v: Verheyen, N D, Kienreich, K, Gaksch, M, van Ballegooijen, A J, Grübler, M R, Hartaigh, B O, Schmid, A, Fahrleitner-Pammer, A, Kraigher-Krainer, E, Colantonio, C, Belyavskiy, E, Treiber, G, Catena, C, Brussee, H, Pieske, B, März, W, Tomaschitz, A & Pilz, S 2015, ' Plasma Parathyroid Hormone Is Independently Related to Nocturnal 3. Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study. ', Journal of Hypertension, vol. 2015 .
Journal of Hypertension, 2015. Lippincott Williams and Wilkins

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::47acc124adc7875a25872e08a226fbbb
https://research.vu.nl/en/publications/ab2df7d4-7836-4e17-9495-13632adf7c0d

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.